T3011
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for T3011, covering 2022-10-28 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of T3011 in Subjects With Advanced Melanoma [Phase 1, Phase 2]